Masimo Corporation (LON:0JZ2)
145.97
+3.78 (2.66%)
At close: Sep 5, 2025
Masimo Employees
Masimo had 3,600 employees as of December 28, 2024. The number of employees decreased by 200 or -5.26% compared to the previous year.
Employees
3,600
Change (1Y)
-200
Growth (1Y)
-5.26%
Revenue / Employee
436.26K GBP
Profits / Employee
-93.01K GBP
Market Cap
5.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 3,600 | -200 | -5.26% |
Dec 30, 2023 | 3,800 | -200 | -5.00% |
Dec 31, 2022 | 4,000 | 1,800 | 81.82% |
Jan 1, 2022 | 2,200 | 200 | 10.00% |
Jan 2, 2021 | 2,000 | 400 | 25.00% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Masimo News
- 1 day ago - How Is The Market Feeling About Masimo? - Benzinga
- 2 days ago - Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - Masimo to Present in the Wells Fargo Healthcare Conference - Business Wire
- 13 days ago - Steve Jobs Hated Being Photographed — But Called This Portrait 'The Best Picture Ever Taken Of Me' - Benzinga
- 14 days ago - Gear News of the Week: Always-Recording Smart Glasses, and Google Teases a New Nest Speaker - WIRED
- 16 days ago - US Customs sued by Masimo over approval of Apple Watch imports with blood oxygen feature - Seeking Alpha
- 16 days ago - Masimo Sues US Customs Over Apple Watch Import Amid Patent Dispute - GuruFocus
- 16 days ago - Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights - Benzinga